Crossmark

Mesothelin (MSLN) is Highly Expressed in Triple Negative Breast Cancer and is Associated with Enhanced Cell Proliferation and Proinflammatory Tumor Microenvironment

Crossref DOI link: https://doi.org/10.1245/s10434-025-17117-y

Published Online: 2025-03-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hagerty, Brendan L.

Sato, Takumi

Wu, Rongrong

Ishikawa, Takashi

Takabe, Kazuaki https://orcid.org/0000-0002-6435-4241
License Information

Text and Data Mining valid from 2025-03-13

Version of Record valid from 2025-03-13
More Information

Article History

Received: 4 November 2024

Accepted: 18 February 2025

First Online: 13 March 2025

Disclosures

: The authors have no potential conflict of interest to disclose.

Document is current

Any future updates will be listed below